|Bid||24.50 x N/A|
|Ask||25.50 x N/A|
|Day's range||23.60 - 25.40|
|52-week range||12.26 - 48.00|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||21 Jun 2021 - 25 Jun 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Unfortunately, investing is risky - companies can and do go bankrupt. But when you pick a company that is really...
The Open Orphan (ORPH) share price has fallen 25% in two months! Zaven Boyrazian investigates what caused this drop, and if now is a good time to buy. The post Is the drop in the Open Orphan (ORPH) share price a buying opportunity? appeared first on The Motley Fool UK.
Open Orphan has signed a contract with Imperial College London as part of a Wellcome Trust funded initiative to manufacture a COVID challenge virus.